Mowery, Y. M., Ballman, K. V., Hong, A. M., Schuetze, S., Wagner, A. J., Monga, V., … Kirsch, D. G. (2024). SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Mowery, Yvonne Marie, Karla V. Ballman, Angela M. Hong, Scott Schuetze, Andrew J. Wagner, Varun Monga, Rachel Heise, et al. “SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Mowery YM, Ballman KV, Hong AM, Schuetze S, Wagner AJ, Monga V, et al. SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Mowery, Yvonne Marie, et al. “SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Mowery YM, Ballman KV, Hong AM, Schuetze S, Wagner AJ, Monga V, Heise R, Attia S, Choy E, Burgess MA, Bae S, Pryor D, Van Tine BA, Tinoco G, Chmielowski B, Freeman CR, Van De Rijn M, Brigman BE, Riedel RF, Kirsch DG. SU2C-SARC032: A randomized trial of neoadjuvant RT and surgery with or without pembrolizumab for soft tissue sarcoma. JOURNAL OF CLINICAL ONCOLOGY. 2024.